Langerhans' cell histiocytosis (Histiocytosis X, Eosinophilic granulomatosis): Difference between revisions
Ttenbergen (talk | contribs) m Text replacement - "== Related Articles == {{EndPlaceHolder}} {{Related Articles}}" to "== Related Articles == {{Related Articles}} {{EndPlaceHolder}}" |
Ttenbergen (talk | contribs) mNo edit summary |
||
(16 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
See [[Malignancy (clonal disorder) of blood or lymphoid tissue, NOS]] instead. | |||
{{ICD10 dx | {{ICD10 dx | ||
| ICD10 Code=D76.0 | |ICD10 Code=D76.0 | ||
| | |StopDate=2020/10/27 | ||
}} | }} | ||
== Additional Info == | == Additional Info == | ||
*Langerhans' cells are white blood cells in the immune system that normally play an important role in protecting the body against viruses, bacteria and other invaders. They are found in the skin, lymph nodes, spleen, bone marrow and lungs. | |||
*Langerhans cell histiocytosis (LCH) is a rare disease involving clonal proliferation of Langerhans cells, abnormal cells deriving from bone marrow and capable of migrating from skin to lymph nodes. Clinically, its manifestations range from isolated bone lesions to multisystem disease. | |||
*Eosinophilic granuloma, also known as pulmonary histiocytosis X (PHX) or pulmonary Langerhans cell histiocytosis X (PLCH), is an uncommon interstitial lung disease that is epidemiologically related to tobacco smoking | |||
=== Legacy === | |||
* this dx was included in error | |||
* existing records in CFE have been changed to [[Malignancy (clonal disorder) of blood or lymphoid tissue, NOS]] (C96) instead | |||
== Alternate ICD10s to consider coding instead == | == Alternate ICD10s to consider coding instead or in addition == | ||
== Candidate [[Combined ICD10 codes]] == | |||
== Related CCI Codes == | |||
{{Data Integrity Check List}} | |||
== Related Articles == | == Related Articles == | ||
{{Related Articles}} | {{Related Articles}} | ||
{{ICD10 footer}} | |||
{{EndPlaceHolder}} | {{EndPlaceHolder}} |